VDR and melanoma: Moreover, many studies have addressed the polymorphisms of the vitamin D receptor in several cancers including ovarian carcinoma [5], breast cancer [6], colorectal cancer [7], non-Hodgkin lymphoma [8], renal cancer [9], oral squamous cell carcinoma [10], esophageal adenocarcinoma [11], non-small cell lung cancer [12], prostate cancer [13], and melanoma [14], [15].